These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 18829545)
21. Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity. Yang H; Zhao R; Yang HY; Lee MH Oncogene; 2005 Mar; 24(11):1924-35. PubMed ID: 15688030 [TBL] [Abstract][Full Text] [Related]
22. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277 [TBL] [Abstract][Full Text] [Related]
23. Co-activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factors. Li X; Hoeppner LH; Jensen ED; Gopalakrishnan R; Westendorf JJ J Cell Biochem; 2009 Oct; 108(2):378-87. PubMed ID: 19585539 [TBL] [Abstract][Full Text] [Related]
24. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation. Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887 [TBL] [Abstract][Full Text] [Related]
25. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway. Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813 [TBL] [Abstract][Full Text] [Related]
26. A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation. Chien J; Narita K; Rattan R; Giri S; Shridhar R; Staub J; Beleford D; Lai J; Roberts LR; Molina J; Kaufmann SH; Prendergast GC; Shridhar V Oncogene; 2008 Dec; 27(58):7223-34. PubMed ID: 18806825 [TBL] [Abstract][Full Text] [Related]
27. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1. Kröger A; Stirnweiss A; Pulverer JE; Klages K; Grashoff M; Reimann J; Hauser H Cancer Res; 2007 Apr; 67(7):2972-81. PubMed ID: 17409403 [TBL] [Abstract][Full Text] [Related]
28. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Bates DO; Cui TG; Doughty JM; Winkler M; Sugiono M; Shields JD; Peat D; Gillatt D; Harper SJ Cancer Res; 2002 Jul; 62(14):4123-31. PubMed ID: 12124351 [TBL] [Abstract][Full Text] [Related]
29. Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. Chen J; Futami K; Petillo D; Peng J; Wang P; Knol J; Li Y; Khoo SK; Huang D; Qian CN; Zhao P; Dykema K; Zhang R; Cao B; Yang XJ; Furge K; Williams BO; Teh BT PLoS One; 2008; 3(10):e3581. PubMed ID: 18974783 [TBL] [Abstract][Full Text] [Related]
30. Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteins. Hedberg Y; Ljungberg B; Roos G; Landberg G Int J Cancer; 2004 Mar; 109(2):189-93. PubMed ID: 14750168 [TBL] [Abstract][Full Text] [Related]
31. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma. Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759 [TBL] [Abstract][Full Text] [Related]
32. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells. Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243 [TBL] [Abstract][Full Text] [Related]
33. Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin. Hudon V; Sabourin S; Dydensborg AB; Kottis V; Ghazi A; Paquet M; Crosby K; Pomerleau V; Uetani N; Pause A J Med Genet; 2010 Mar; 47(3):182-9. PubMed ID: 19843504 [TBL] [Abstract][Full Text] [Related]
34. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377 [TBL] [Abstract][Full Text] [Related]
35. CIAPIN1 inhibits the growth and proliferation of clear cell renal cell carcinoma. He L; Wang H; Jin H; Guo C; Xie H; Yan K; Li X; Shen Q; Qiao T; Chen G; Chai N; Zhao L; Dong Q; Zheng Y; Liu J; Fan D Cancer Lett; 2009 Apr; 276(1):88-94. PubMed ID: 19081179 [TBL] [Abstract][Full Text] [Related]
36. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma. Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653 [TBL] [Abstract][Full Text] [Related]
37. The coactivator activator CoAA regulates PEA3 group member transcriptional activity. Verreman K; Baert JL; Verger A; Drobecq H; Ferreira E; de Launoit Y; Monte D Biochem J; 2011 Nov; 439(3):469-77. PubMed ID: 21736557 [TBL] [Abstract][Full Text] [Related]
38. Overexpression of Csk-binding protein contributes to renal cell carcinogenesis. Feng X; Lu X; Man X; Zhou W; Jiang LQ; Knyazev P; Lei L; Huang Q; Ullrich A; Zhang Z; Chen Z Oncogene; 2009 Sep; 28(37):3320-31. PubMed ID: 19581936 [TBL] [Abstract][Full Text] [Related]
39. Energy stress-induced lncRNA FILNC1 represses c-Myc-mediated energy metabolism and inhibits renal tumor development. Xiao ZD; Han L; Lee H; Zhuang L; Zhang Y; Baddour J; Nagrath D; Wood CG; Gu J; Wu X; Liang H; Gan B Nat Commun; 2017 Oct; 8(1):783. PubMed ID: 28978906 [TBL] [Abstract][Full Text] [Related]
40. The Ets transcription factor ELF5 functions as a tumor suppressor in the kidney. Lapinskas EJ; Svobodova S; Davis ID; Cebon J; Hertzog PJ; Pritchard MA Twin Res Hum Genet; 2011 Aug; 14(4):316-22. PubMed ID: 21787113 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]